Tai­wan-based CD­MO Bo­ra Phar­ma to pay up to $210M for Up­sh­er-Smith to ex­pand in­to the US

Tai­wan-head­quar­tered CD­MO Bo­ra Phar­ma­ceu­ti­cals is buy­ing gener­ic man­u­fac­tur­er Up­sh­er-Smith Lab­o­ra­to­ries for up to $210 mil­lion to ex­pand op­er­a­tions in­to the US for the first time …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER